Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$502 Buy
+2
New +$654 ﹤0.01% 3396
2024
Q2
Sell
-2
Closed -$588 3505
2024
Q1
$708 Hold
2
﹤0.01% 3877
2023
Q4
$512 Buy
+2
New +$545 ﹤0.01% 4125
2023
Q2
Sell
-2
Closed -$464 3887
2023
Q1
$541 Buy
+2
New +$491 ﹤0.01% 4146
2022
Q3
Sell
-21,600
Closed -$5.24M 4890
2022
Q2
$5.26M Buy
21,600
+21,597
+719,900% +$5.29M 0.01% 1335
2022
Q1
$1K Hold
3
﹤0.01% 4985
2021
Q4
$1K Sell
3
-14,063
-100% -$2.97M ﹤0.01% 5007
2021
Q3
$2.99M Buy
14,066
+14,061
+281,220% +$3.24M 0.01% 1574
2021
Q2
$1K Buy
+5
New +$1.23K ﹤0.01% 4922
2019
Q2
Sell
-8,669
Closed -$1.55M 3602
2019
Q1
$1.65M Buy
+8,669
New +$1.66M 0.01% 1443

Other funds holding AMGN

PEAK6 Investments's AMGN Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Amgen (AMGN) in Q3 2024: 2 shares worth $502. The stake represents ﹤0.01% of the portfolio and ranks #3396 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in AMGN as recently as Q1 2024.

PEAK6 Investments first reported a position in AMGN in Q1 2019 and has held it in 10 quarters since. The position peaked at $5.26M in Q2 2022. 2,823 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • PEAK6 Investments held 2 shares of Amgen worth $502 as of Q3 2024.
  • Amgen was a new PEAK6 Investments position in Q3 2024.
  • Amgen made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3396 holding.
  • PEAK6 Investments first reported a position in Amgen in Q1 2019 and has held it in 10 quarters since.
  • PEAK6 Investments's Amgen position peaked at $5.26M in Q2 2022.
  • 2,823 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.